98%
921
2 minutes
20
Transgender and gender diverse (TGD) patients experience challenges in health care settings, including stigma, lack of culturally competent providers, and suboptimal gender-affirming care. However, differences in patient satisfaction between TGD patients compared with cisgender patients have been inadequately studied. This study aimed to assess such differences in patient satisfaction with care received in a large academic medical care system in Boston, Massachusetts. Routine patient satisfaction surveys were fielded from January to December 2021 and were summarized. Logistic regression models compared low net promoter scores (NPS; ≤6) between gender identity groups (cisgender women, transmasculine and nonbinary/genderqueer people assigned female at birth [AFAB], transfeminine and nonbinary/genderqueer people assigned male at birth) relative to cisgender men, adjusting for age, race, ethnicity, education, inpatient/outpatient service delivery, and distance from medical center. Of 94,810 patients, 246 (0.3%) were TGD and 94,549 (99.7%) were cisgender. The mean age was 58.3 years (standard deviation = 16.6). Of the total sample, 17.0% of patients were people of color, 6.6% were Hispanic/Latinx, 48.6% were college graduates, and 2.6% had received inpatient care. In general, patient satisfaction with health care received was lower for TGD patients than for cisgender patients (7.3% vs. 4.5% reporting low NPS; adjusted odds ratio [aOR] = 1.14; 95% confidence interval [CI] = 0.70-1.85). Transmasculine and nonbinary/genderqueer patients AFAB had elevated odds of low NPS compared with cisgender men (8.8% vs. 3.6%; aOR = 1.71; 95% CI = 1.02-2.89). Future research is warranted to better understand factors driving lower ratings among TGD patients. Health care quality improvement efforts are needed to address gender identity inequities in care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/lgbt.2023.0034 | DOI Listing |
Pediatr Ann
September 2025
Division of Gynecology, Boston Children's Hospital, Department of Surgery, Harvard Medical School.
Based on extensive evidence, gender-affirming care (GAC) is endorsed by numerous medical societies as the gold standard for supporting youth who are transgender and gender diverse (TGD). Unfortunately, there remain barriers to accessing GAC and an ongoing risk of gender identity-based mistreatment for youth who are TGD accessing all forms of health care. Gynecologic care is commonly accessed by youth who are TGD as part of medical gender affirmation, with needs ranging from hormone management, menstrual suppression, contraception counseling, and surgical consultation.
View Article and Find Full Text PDFBackground: To help reduce mental health disparities in the transgender and gender diverse (TGD) population, there is a need to equip future psychiatric mental health nurse practitioners (PMHNPs) with affirming care competence.
Method: This study evaluated a multimodal education program that combined eLearning with two virtual standardized patient (SP) simulations to teach PMHNP students to provide affirming mental health care to TGD people.
Results: Slight increases in knowledge and attitudes were not practically applicable.
J Pediatr Adolesc Gynecol
September 2025
Division of Adolescent Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Study Objectives: This study compares the demographic characteristics and experiences of three different groups of adolescent and young adults (AYAs) seeking non-sedated intrauterine device (IUD) insertion in the outpatient setting: (1) cisgender individuals, (2) transgender and gender diverse (TGD) individuals receiving gender-affirming testosterone therapy, and (3) TGD individuals not receiving gender-affirming testosterone therapy.
Methods: This retrospective cohort study included AYAs age 13 to 21 years seeking IUD insertion. Data were obtained from the electronic health record via a pre-existing, multi-institutional shared quality improvement (QI) collaborative.
Clin J Am Soc Nephrol
September 2025
VA Greater Los Angeles Health Care System, Department of General Internal Medicine, Department of Medicine.
This review examines the effects of gender-affirming hormone therapy (GAHT) on kidney health in transgender and gender diverse (TGD) populations, which face significant challenges in accessing medical care. GAHT, typically involves estrogen therapy for transgender women and transfeminine individuals, testosterone therapy for transgender men and transmasculine individuals, and therapy regimens for individuals who are nonbinary or identify with another gender not culturally assigned to their sex assigned at birth. Hormone therapy influences biomarkers such as creatinine and cystatin C, which are used in estimating glomerular filtration rate (eGFR).
View Article and Find Full Text PDFJ Gen Intern Med
September 2025
Center for Transgender Medicine and Surgery, Mount Sinai Health System, New York, NY, USA.
Background: Few consensus guidelines exist regarding screening mammography recommendations for transgender and gender diverse (TGD) individuals.
Objective: Our study aimed to assess the utilization of screening mammograms in a large cohort of TGD individuals at a single institution and the factors influencing mammogram uptake.
Design: Retrospective cross-sectional study.